WBDR Research Support Program

The World Bleeding Disorders Registry (WBDR) Research Support Program (RSP) is designed to motivate and support hemophilia treatment centres (HTC) to collect, analyze and use their WBDR data.

APPLICATION CYCLE AND DEADLINES

Submission of research proposals startMarch 1, 2026
Submission of research proposals deadlineMay 1, 2026
Review and selection of research projectsMay – June 2026
Announcement of recipientsMid-July 2026
Funds disbursedJuly 2026

CRITERIA

The WFH WBDR RSP will fund up to 15 projects per year.

  • Funding of $2,000 to $5,000 USD per project
  • Project duration can be one or two years

ELIGIBILITY

The program is open to recognized HTCs* from any country, as long as they are registered in the WBDR**.

Only research proposals that use WBDR will be eligible.

*The applicant must be the HTC Director or the primary contact person for the WBDR. Only one application per HTC is accepted, per cycle.

**HTC that has completed a WBDR registration form and is either applying for WBDR approval from their institutional review board or ethics committee or has received ethical approval.

All HTCs are welcome to submit a research proposal. Priority may be given to HTCs with limited data collection experience in their country and/or HTCs in low and middle-income countries.

SELECTION CRITERIA

WFH WBDR RSP will be awarded to projects that best align with the following criteria:

  • Novelty of the research objectives
  • Importance of the research to influence policy or build evidence-based advocacy
  • Demonstration of the value of data collection
  • Needs of the country
  • Existence of limited data collection activities
  • Sustainability plan
  • Feasibility of completing the research within the proposed timeframe and budget

Collaboration is recommended and HTCs within a country are encouraged to apply as a group. The WFH Medical Advisory Board and the WFH WBDR Steering Committee have identified the following eligible collaboration opportunities:

  • Country-level collaboration between all HTCs in a country
  • International research partnerships and comparative analysis between HTCs

Please note that this list is intended to provide guidance on the type of collaboration that might be possible. Collaboration is not a submission requirement.

CONDITIONS

Application forms are available in English, French, Spanish, and Russian.

  • Applicants are responsible for determining if their research project requires ethics approval and follows the appropriate guidelines from their national/institutional research ethics board. Please note that HTCs participating in the WBDR must first obtain ethics approval from their local institution or ministry of health in order to enter patient data into the WBDR database. With the exception of fees required by your research ethics board, funds will not be released before ethical approval to participate in the WBDR has been obtained.
  • Applicants are responsible for ensuring that they can receive funds from the WFH according to the laws and regulations of their HTCs and country. HTCs that are not able to receive funds through the usual means will not be considered for funding.
  • The funds must contribute towards the direct costs of the research program or project for which the funds were awarded. This can include any part of the WBDR approval process or data management process: obtaining ethics approval, collecting data, entering the data in the WBDR, cleaning the data, analyzing the data or writing up the report. Other eligible costs can include staff, materials, internet access, and supplies. Costs that are not eligible include investigator or clinical staff salaries, travel expenses, or clinic reimbursements. Note that any overhead costs should be included in your project budget.
  • The WBDR Research Support Committee reserves the right to modify the budget and award an amount that is deemed acceptable
  • The HTC must commit to inviting all their patients with hemophilia and VWD in the WBDR (as is the case for any HTC participating in the WBDR) and must ensure that their data is clean and of high quality. Data quality is assessed by the WFH on an ongoing basis.
  • Two-year funding will be disbursed in two annual payments and will be sent to the financial officer of the host institution
  • Applications that receive funds must acknowledge the support of the WFH WBDR Research Support Program in all publications and oral presentations relating to the funded research
  • To ensure continued funding for the second year, a short progress report is required. A final report is required upon completion of the research project. Financial reporting must be included in the progress and final reports.

APPLICATION PROCESS

Research proposal submissions will be accepted from March 1, 2026 until May 1, 2026. All submissions are peer-reviewed by the WBDR Research Support Committee and successful applicants will be notified by mid June 2026. Completed research proposals must be sent by email to [email protected].

Please read the criteria and conditions before submitting a research proposal. Data analysis does not need to be high level statistical analysis, it could be simple summary statistics of the HTC data.

Examples of potential research questions are the following:

  • What is the change in bleeding events before and after starting low-dose prophylaxis?
  • What is the prevalence of intra-cranial bleeding among hemophilia patients at my HTC? Is it consistent with what is reported in the literature?
  • What is the average age of the first bleeding event among hemophilia patients at my HTC?

Download the WFH WBDR Research Proposal – Application Form:

For more information, contact [email protected].

Did you know?

The WFH eLearning Platform is your one-stop-shop for all your educational resource needs. With just a few clicks, you can find everything you need on hemophilia and other inherited bleeding disorders

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.